Zdrowie i gospodarka · 4.03.1996
Drug Export; Abbott MATRIX HCV 2.0
The Food and Drug Administration (FDA) is announcing that Abbott Laboratories has filed an application requesting approval for the export of the human biological product Abbott MATRIX HCV 2.0 to Australia, New Zealand, and to The Federal Republic of Germany solely for the purpose of further export to Austria, Belgium, Denmark, Finland, Iceland, Ireland, Italy, The Netherlands, Norway, Portugal, Spain, Sweden, and The United Kingdom.